MR‐proADM as marker of endotheliitis predicts COVID‐19 severity-Reference-Cited by-同舟云学术

MR‐proADM as marker of endotheliitis predicts COVID‐19 severity

Published:2021-02-20 Issue:5 Volume:51 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

García de Guadiana‐Romualdo Luis¹^ORCID,Calvo Nieves María Dolores²,Rodríguez Mulero María Dolores³,Calcerrada Alises Ismael⁴,Hernández Olivo Marta⁵,Trapiello Fernández Wysali²,González Morales Mercedes¹,Bolado Jiménez Cristina⁶,Albaladejo‐Otón María Dolores¹,Fernández Ovalle Hilda⁷⁸,Conesa Hernández Andrés⁹,Azpeleta Manrique Eugenio⁶,Consuegra‐Sánchez Luciano¹⁰,Nogales Martín Leonor¹¹,Conesa Zamora Pablo¹,Andaluz‐Ojeda David¹¹

Affiliation:

1. Laboratory Medicine Department Hospital Universitario Santa Lucía Cartagena Spain

2. Laboratory Medicine Department Hospital Clínico Universitario Valladolid Spain

3. Intensive Care Unit Hospital Universitario Santa Lucía Cartagena Spain

4. Primary Care Medina del Campo Urbano Medina del Campo, Valladolid Spain

5. Pneumology Department Hospital Universitario Santa Lucía Cartagena Spain

6. Emergency Department Hospital Clínico Universitario Valladolid Spain

7. Primary Care Valladolid West Area Centro de Salud Parque Alameda‐Covaresa Valladolid Spain

8. Endocrinology and Clinical Nutrition Research Center (ECNRC) Universidad de Valladolid Valladolid Spain

9. Emergency Department Hospital Universitario Santa Lucía Cartagena Spain

10. Cardiology Department Hospital Universitario Santa Lucía Cartagena Spain

11. Intensive Care Medicine Department Hospital Clínico Universitario Valladolid Spain

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13511

Reference42 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. WHO.Coronavirus disease 2019 (COVID‐19) situation report. October 24 2020.https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019. Accessed January 2 2021.

3. Endothelial cell infection and endotheliitis in COVID-19

4. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

5. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Adrenomedullin as a Predictive Marker of the Risk of Death and Adverse Clinical Events: A Review of the Literature;Journal of Clinical Medicine;2024-08-16

2. A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections;Cells;2024-05-22

3. Midregional‐proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta‐analysis;European Journal of Clinical Investigation;2024-04-17

4. Endothelial dysfunction and disease severity in COVID-19: Insights from circulating Tang cell counts as a potential biomarker;International Immunopharmacology;2024-03

5. Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?;International Journal of Molecular Sciences;2023-12-13